|Free Dividend Report|
|Stock Splits Calendar|
|MYGN Stock Split History|
|Preferred Stock Newsletter|
|MYGN Options Chain|
|MYGN Message Board|
Myriad Genetics (MYGN) has 2 splits in our MYGN split history database. The first split for MYGN took place on September 12, 2000. This was a 2 for 1 split, meaning for each share of MYGN owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. MYGN's second split took place on March 26, 2009. This was a 2 for 1 split, meaning for each share of MYGN owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split.
When a company such as Myriad Genetics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the MYGN split history from start to finish, an original position size of 1000 shares would have turned into 4000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Myriad Genetics shares, starting with a $10,000 purchase of MYGN, presented on a split-history-adjusted basis factoring in the complete MYGN split history.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-0.77%|
|About Myriad Genetics|
|Myriad Genetics is precision medicine company acting as an advisor to transform patient lives through molecular diagnostics. Co.'s molecular diagnostic tests are designed to analyze genes, their expression levels and corresponding proteins to assess an individual's risk for developing disease later in life, diagnose disease, determine a patient's likelihood of responding to a particular drug, or disease recurrence and assess a patient's risk of disease progression. Co. also provides biomarker discovery and pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries utilizing its multiplexed immunoassay technology. According to our MYGN split history records, Myriad Genetics has had 2 splits.|
|MYGN Split History Table|
|09/12/2000||2 for 1|
|03/26/2009||2 for 1|
|Healthcare Stock Splits|
|MYGN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
Also explore: MYGN shares outstanding history